PROGRAMME COMMITTEE CO-CHairs
Motivating prevention and healthy behaviours
Dr Mona Saraiya - Senior Medical Officer, Center for Disease Control and Prevention (CDC)
Prof. Surendra S.Shastri - University of Texas MD Anderson Cancer Center, United States
The sessions within Track 1 focus on primary prevention, including health promotion, examples of best practice in new evidence based prevention strategies, vaccines, as well as new areas of development in policy & planning, programme management, policy, communications, and education.
- What can we learn from successful prevention campaigns and programmes, including their communications strategies, monitoring and measurement?
- How to leverage new technologies to support behavioural cancer prevention programmes?
- How can we quantify the economic value of cancer prevention activities?
- How does continuous community and professional education, especially for primary care providers, influence effective health promotion and adoption of healthy lifestyles?
- What are the benefits and the impact of nutrition research on prevention?
- How multisectoral collaboration between governments (national & local leaders) and health professionals (cross-diseases) or the private sector can facilitate prevention programmes?
- What are the strategies to increase public’s awareness of cancer through immunisation and vaccination promotion programmes, and the system drivers influencing their dissemination?
- How can social media strategies and related data collection leverage social influence & behaviour change?
- What are the best strategies to efficiently communicate scientific discoveries in prevention health?
- What should we stop doing in cancer prevention? The things we know do not work.
Advances in screening and early detection
Prof Jon Emery - Herman Professor of Primary Care Cancer Research at the University of Melbourne and Western Health, Australia
Ms Sara Hiom - Director of Early Diagnosis, Cancer Research UK and NAEDI, UK
Track 2 will address the needs for improved systems and pathways that result in cancer being found and treated at an earlier stage of development. It will include issues about improvements in existing screening efforts and programs, addressing barriers to establishing proven screening programs, more effective initiatives to systematically detection cancer earlier through primary care and other mechanisms, improved diagnosis strategies, and improved pathways to access to. The sessions should also highlight the scientific, clinical and technological advancements such as biotech breakthroughs as well as the progress in promising trials.
- What are the outcomes and the effectiveness of opportunistic screening for high risk populations with a low socioeconomic status?
- How can nano and other technology benefit early detection, diagnosis?
- What are the best policies and practices for early detection and screening in low resource environments?
- Do sectors other than health have a role to play in early detection?
- What should we stop doing in screening and early detection?
- Fitting cervical screening technologies to populations
- Latest on lung cancer screening
- Challenges and solution in breast cancer screening
- Community programmes promoting symptom reporting to primary care
Improved and sustainable healthcare Systems
This track adds value by channelling intellectual effort, collaborations, access to shared resources to stimulate the dialogue about implementing global commitments at a national level but also strengthening national, regional and local health systems and guiding quality improvement across many aspects of sustainable development, policy and planning, infrastructure, measurement, reporting and performance.
- How can we achieve equity in cancer care?
- What are the barriers to and facilitators of quality care?
- How to maximise the potential of health information technology in supporting modern cancer treatment and care?
- What progress has been made around patient-centred cancer treatment planning practice? What is a realistic view of new treatments?
- Access, cost, equity and efficacy?
- How to overcome the lack of capacity and service delivery as well as severe shortages of health workers in low-income and resource settings?
- Essential medicines: how to build an effective procurement and supply chain management for primary healthcare facilities?
- How to define which care setting is most cost-effective and appropriate to the patient experience and outcome?
- How to measure evidence protocols, service utilisation rates, and performance on quality, costs, and outcomes?
- How to create and promote increased transparency on health care system performance to guide improvement efforts and long term impact (increase the availability of information on the quality, prices and cost, outcomes of care, data collection and use)?
- What is required to develop effective leadership and governance, including transparency and accountability?
- What are the building blocks of a robust and sustainable health infrastructure?
- What are the new models for multisectoral/cross-diseases partnerships and collaborative practice?
- How to adapt to a rapid healthcare delivery landscape transformation?
- How women empowerment and education can influence health systems & services’ strengthening?
- Cancer control planning: what kind of framework for research and programmes in low and middle-income countries?
- Building bridges between planning and implementation of cancer service delivery
- How can a multi-stakeholder approach and action can influence the implementation of global health and cancer commitments at national levels?
- How to define the investment priorities for outcome-driven sustainable healthcare systems and services?
Maximising quality of life and death. Empowering
Dr Anna Boltong - Head of Cancer and Information Support Service at Cancer Council Victoria, Australia
Dr Ednin Hamzah - CEO of Hospis Malaysia
The track should examine novel interventions to support patient engagement and survivorship in a variety of cancer care delivery settings. It focuses on patient experience and quality of outcome, exploring patient and family engagement, wrestles with rights and expectations of cancer patients and their families and the challenges of access, fairness and consistency of experience and care. It will explore the role of complimentary therapies, identify experiences with alternative treatments and invite challenging discussions about balance of investment and patient power. It invites exploration of measurement issues, prioritisation of service delivery, communication skills of health care professionals, tools to drive health care facility culture and survivorship. Fundamental questions around palliative care, pain relief and end of life issues are invited.
- Why are the psychosocial parameters that surround cancer treatment as important as the clinical and molecular aspects of the disease?
- What novel models of care delivery can improve access to palliative care and pain relief?
- How to overcome discrimination or patients’ bias in accessing palliative care and pain relief?
- What are complimentary medicines and how can they benefit cancer treatment and care?
- What are the core factors influencing primary health care workers in a patient centred approach?
- Why and how to define the goal of shared decision making as a component of patient engagement in oncology?
- What are the patients’ considerations/needs in determining treatment and care priorities and associated implementation strategies?
- What are the new communications opportunities with patients and their families in the digital era?
- How to maximise new technologies and media landscape (ie: mobile apps, online patient communities, patient portals) to encourage patients’ engagement and change in health behaviours and health outcomes?
- How to leverage the value and use of patient generated data (including understanding of data privacy, lack of user friendly app, stand-alone applications not integrated into clinical information systems or not part of the clinician workflow, etc...)?
- What are the innovative education gateways that support the health care professionals and community efforts to improve the quality of patient care?
- How can culture, religion and ethnicity influence care patients’ experiences?
- How the evolving role of oncology nurses, care givers and other care professionals can change the way to improve care?
- What are the various aspects of patient self-management as part of the broader chronic care model?
- What approaches are effective for patient distress?
- What measures and actions can support families on their cancer journey?
Raising funds and attracting resources
Ms Mayse Nababteh - Head of International Fundraising and Development Department at King Hussein Cancer Foundation, Jordan
Ms Lynda Thomas - CEO of Macmillan Cancer Support, UK
This new track brings together expertise in fundraising, grant application writing, relationship development essential to capturing funds to facilitate effective cancer control. Income generation options from fund raising events, wills and bequests, lotteries, corporate relationship development, cause related marketing, branding and promotion, government grant writing, proposal development for charitable trusts. The scope will be from grass roots community fund raising through to negotiating deals with the big end of town. Shared goals, public private partnerships, social investment and strange bedfellows will be under the microscope.
- What type of funding and fundraising models can support and advance prevention?
- Are pension funds, sovereign wealth funds and insurance companies tomorrow’s investors in cancer research and treatment?
- What are the risks and benefits of cause related marketing
- There are some people we simply should not take money from. Who are they and how do we decide?
- How is a good legacies, wills and bequests best managed? Opportunities and pitfalls
- The trends in fund raising events. What is working – what is struggling?
- Lotteries, raffles, gambling and cancer fund raising. Lessons learned.
- The trends in fund raising campaigns. What is working – what is struggling?
- Lotteries, raffles, gambling and cancer fund raising. Lessons learned.
- Writing philanthropic grant applications: how to and what no to do
- Accessing high net worth individuals. Is there a method in bringing the wealthy on board for cancer control?
- Fund raising and big data. Nuts and bolts systems in a digital age
- Fund raising rip offs – how to avoid the major catastrophes
- Partnerships with the for-profit sector: Going in with your eyes open
- Working with government: Surviving the complex world of government, politics and election cycles.
- Raising funds collaboratively with other like-minded NFPs and NGOs.